The U.S. Food and Drug Administration (FDA) issued a warning on March 15, 2021, advising patients and medical providers regarding a higher-than-anticipated risk fracture of the polyethylene component of the Stryker Scandinavian Total Ankle Replacement devices (STAR Ankle). Should the component break, repair surgery or device replacement could be necessary.
According to the FDA, the potential risk of fracture of the polyethylene component is present in all STAR ankle devices, regardless of manufacture or distribution date. However, the FDA says the STAR Ankle may still be useful for patients with lower activity levels, but those who lead active lifestyles or are younger than age 55 may be at higher risk for plastic component fracture within three to four years of implantation.
Stryker STAR Ankle Replacement Device
What is the STAR Ankle Replacement?
The STAR Ankle replacement is meant to be used as a total ankle prosthetic, replacing the painful, arthritic ankle joint present in a patient who has been diagnosed with osteoarthritis, rheumatoid arthritis, or post-traumatic ankle arthritis. The device is composed of a tibial plate, a sterilized polyethylene component, a talar component, and is designed to allow for some normal ankle movement and function.
The FDA has made recommendations for those who already have a STAR Ankle, or are considering having one implanted:
- Talk to your doctor if you experience any new and increasing pain, inability to support weight, grinding or other noise, or instability in the STAR Ankle replacement.
- Ask your medical provider to perform a physical exam of your ankle and take X-rays to assess your STAR Ankle. Computed tomography (CT) may be warranted to determine whether the plastic component is broken.
- If you experience a problem with your STAR ankle replacement, report the issue through the FDA’s MedWatch Voluntary Reporting Form.
Caregivers should discuss the risks and benefits of all treatment options for painful arthritic ankle joints, including the STAR Ankle, and should closely monitor patients who have had the device implanted. Prompt reporting of problems with the device can help the FDA identify its associated risks and keep the public informed.
Our attorneys at Childers, Schlueter & Smith have extensive knowledge regarding defective medical devices, and may be able to help you through your situation. If you have sustained injuries from a defective product, give us a call for a free consultation.
Other Medical Devices News
The FDA warns that Synovo Total Hip Systems, implanted after 2019, pose risks of failure and injury. Patients experiencing symptoms should consult our CSS lawyers to explore legal options for compensation.
Thousands of hernia mesh products have been recalled, but qualifying for a claim requires proof that a defective hernia mesh implant caused your injury.
Damages from a defective hernia mesh implant vary based on each person’s injuries and circumstances. An experienced dangerous medical device attorney can help identify all the losses you may be entitled to recover.
Women nationwide are filing lawsuits after suffering injuries from Paragard IUD breakage—alleging the manufacturer failed to warn of the device’s dangerous design defects.
A voluntary recall affects over 3.5 million Philips Respironics CPAP, BiPAP, and ventilator devices due to foam degradation risks, potentially endangering sleep apnea patients’ health and safety.
Philips Respironics has recalled certain CPAP, BiPAP, and ventilator devices due to degrading sound foam that may release harmful particles and chemicals, posing serious health risks to users.
